The company swung to a $41 million loss in the second quarter and saw sales plummet 22%, but forecasts an upswing in the ...

Ken Moelis is stepping down as CEO, but Moelis & Co. stock stays resilient with a strong case for growth. Learn why the bank's deal pipeline is still strong.

Moelis & Co (NYSE:MC) is set to release its Q2 2025 earnings on Jul 24, 2025. The consensus estimate for Q2 2025 revenue is $269.57 million, and the earnings are expected to come in at $0.22 per ...

EQT and CPP Investments have agreed to acquire El Segundo-based NEOGOV, a provider of human capital management and public ...

It looks like Moelis & Company ( NYSE:MC ) is about to go ex-dividend in the next 3 days. The ex-dividend date ...

Moelis & Co saw 5 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Moelis & Co’s stock price’s past reactions to earnings here.

Moelis & Co (MC) reports a 38% revenue increase, strong cash position, and strategic hires to boost future growth.

Most of the 10 stations going to Gray are located in the south and midwest and will create duopolies across Gray’s existing ...

NEW YORK - Investment bank Moelis & Company (NYSE:MC) reported second quarter 2025 revenues of $365.4 million, a 38% increase from the same period last year, according to a company press release ...

The latest earnings call from Moelis & Company was marked by a generally positive sentiment, underscored by record revenue growth, strategic hiring, and a robust balance sheet. Despite facing ...

The purchase of ten local stations from Allen Media Group is expected to close in the fourth quarter of this year.

CorMedix, a biopharmaceutical company specialising in critical care products, is to acquire Melinta Therapeutics for $300m.